Dr. Michele Lynn Babicky, MD

Dr. Babicky practices at Compass Oncology in Vancouver, Washington.

Dr. Babicky's NPI, 1871742478, was assigned on September 18, 2008. Dr. Babicky holds Oregon license MD188635.

Dr. Babicky's primary practice is Compass Oncology, at 210 Se 136th Ave, Vancouver, WA 98684 in Clark County. The practice phone is (360) 597-1300.

Dr. Babicky's primary practice is Compass Oncology in Vancouver, Washington. Dr. Babicky is also affiliated with Providence St. Vincent Medical Center. The medical group on file is Compass Oncology. Dmand AI also links Dr. Babicky to 2 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babicky practices, 7 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Babicky's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Babicky is licensed in Oregon.

CMS data shows 210 Medicare services from Dr. Babicky across 10 procedure codes in 2024, for 95 Medicare patients. Medicare paid $19,129 for them.

CMS counts 95 Medicare patients who saw Dr. Babicky in 2024. The largest group is 65 to 74, with 49 patients. 63% of them have high blood pressure, and 59% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babicky's median patient age at 64, with 65% women.

In 2024, Dr. Babicky wrote 104 Medicare Part D claims for 59 patients. 89% of them were for generic drugs. CMS names the drug for 55 of them, across 2 drugs with 11 or more claims each, at $412 in total drug cost. In 2021, CMS named 63 claims across 3 drugs.

Dr. Babicky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Babicky as offering telehealth.

Dmand AI links 12 papers to Dr. Babicky, published from 2012 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Education, Medical, Graduate, Fellowships and Scholarships and Internship and Residency. Dr. Babicky has published most often in HPB (Oxford). Dr. Babicky's most frequent co-authors are Adnan Ali Alseidi, MD, Brendan Christopher Visser, MD and Susanne G. Warner, MD.

CMS Open Payments shows 58 general payments to Dr. Babicky from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $2,114.